Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma

NCT06627244 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Uveal Melanoma
Metastatic Uveal Melanoma in the Liver

Interventions

DRUG: Tebentafusp
RADIATION: TheraSphere™ Yttrium-90 Trans-Arterial Radioembolization

Sponsor

University of Miami

Collaborators

[object Object]